Prognostic influence of antidepressant treatment for stable chronic obstructive pulmonary disease patients with depression

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-13003220

Enrollment

Unknown

Registered

2013-05-15

Start date

2013-05-15

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic obstructive pulmonary disease

Interventions

intervention group,:antidepressant treatment

control:placebo

Eligibility

Sex/Gender

All

Age

61 Years to 78 Years

Inclusion criteria

Inclusion criteria: 1. The age of patients>17 years; 2. patients with total HAMD-17 score>=17; 3. all COPD patients meet the diagnostic criteria according to GOLD guidelines, and FEV1/FVC<70%.

Exclusion criteria

Exclusion criteria: 1. Patients with unstable angina or myocardial infarction; 2. Patients with poorly controlled hypertension, systolic blood pressure >=180mmHg, diastolic blood pressure >= 120mmHg; 3. Patients' oxygen saturation <88%; 4. Patients with the limited ability of activity; 5. Patients with severe neurological diseases; 6. Patients with peripheral vascular disease.

Design outcomes

Primary

Measure	Time frame
lung function;quality of life;6-minute walk distance;17-item Hamilton depression rating scale;	—

Countries

China

Contacts

Public ContactYuanqiang He

heyuanqiang168@163.com+86 15152587003

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026